price
CR
NASDAQ · CRVS
Corvus Pharmaceuticals, Inc.
Healthcare · Biotechnology
$12.95
Down-$0.72 (-5.56%)
Updated Sep 16, 2026, 9:18 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 627.78M
- P/E ratio
- -46.21
- Dividend yield
- 0.00%
- 52-week range
- $5.64 – $26.95
- Volume
- 1.4M
- Avg. volume
- 1.02M
Price performance
CRVS price history
1M range · 0 trading sessions · Daily adjusted prices
CRVS does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest CRVS news
The latest Smart Investors Daily articles mentioning CRVS.
Stock researchCompany · Financials
Loading stock research…